Prevalence of advanced hepatic fibrosis and non-invasive scores for type 2 diabetics with MASLD: Prospective study in a resource-limited Indian setting
Data shows that evaluating accessible non-invasive strategies for identifying advanced hepatic fibrosis in patients with Type 2 Diabetes Mellitus and metabolic dysfunction-associated steatotic liver disease shows that these non-invasive scores can reliably identify advanced hepatic fibrosis in routine diabetic care.